Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Organisms at high altitude wikipedia , lookup
Stimulus (physiology) wikipedia , lookup
Haemodynamic response wikipedia , lookup
Membrane potential wikipedia , lookup
Magnesium in biology wikipedia , lookup
Alveolar macrophage wikipedia , lookup
Resting potential wikipedia , lookup
Pre-Bötzinger complex wikipedia , lookup
Homeostasis wikipedia , lookup
CHAPTER 34 Disorders of Acid-Base Balance MECHANISMS OF ACID-BASE BALANCE Acid-Base Chemistry Metabolic Acid and Bicarbonate Production Carbon Dioxide and Bicarbonate Production Production of Noncarbonic Acids and Bases Calculation of pH Regulation of pH Intracellular and Extracellular Buffer Systems Respiratory Control Mechanisms Renal Control Mechanisms Laboratory Tests Carbon Dioxide and Bicarbonate Levels Base Excess or Deficit Anion Gap DISORDERS OF ACID-BASE BALANCE Metabolic Versus Respiratory Acid-Base Disorders Primary Versus Compensatory Mechanisms Metabolic Acidosis Causes Manifestations Treatment Metabolic Alkalosis Causes Manifestations Treatment Respiratory Acidosis Causes Manifestations Treatment Respiratory Alkalosis Causes Manifestations Treatment M etabolic activities of the body require the precise regulation of acid-base balance, which is reflected in the pH of extracellular fluids. Membrane excitability, enzyme systems, and chemical reactions depend on acid-base balance being regulated within a narrow physiologic range to function in an optimal way. Many conditions, pathologic or otherwise, can alter body pH. This chapter has been organized into two sections: mechanisms of acidbase balance and disorders of acid-base balance. Mechanisms of Acid-Base Balance After you have completed this section of the chapter, you should be able to meet the following objectives: ✦ Characterize an acid and a base ✦ Cite the source of metabolic acids ✦ Describe the three forms of carbon dioxide transport and their contribution to acid-base balance ✦ Define pH and use the Henderson-Hasselbalch equation to calculate the pH and to compare compensatory mechanisms for regulating pH ✦ Describe the intracellular and extracellular mechanisms for buffering changes in body pH ✦ Compare the role of the kidneys and respiratory system in regulation of acid-base balance ✦ Explain how potassium and hydrogen ions and how bicarbonate and chloride ions interact in pH regulation Normally, the concentration of body acids and bases is regulated so that the pH of extracellular body fluids is maintained within a very narrow range of 7.35 to 7.45. This balance is maintained through mechanisms that generate, buffer, and eliminate acids and bases. This section of the chapter focuses on acid-base chemistry, the production and regulation of metabolic acids and bicarbonate, calculation of pH, and laboratory tests of acid-base balance. ACID-BASE CHEMISTRY An acid is a molecule that can release a hydrogen ion (H+), and a base is a molecule that can accept or combine with an hydrogen ion.1,2 When an acid (HA) is added to water, it dissociates reversibly to form H+ and anions (A−); for example, HA H+ + A−. The degree to which an acid dissociates and acts as a H+ ion donor determines whether it is a strong or weak acid. Strong acids, such as sulfuric acid, dissociate completely; weak acids, such as acetic acid, dissociate only to a limited extent. The same is true of a base and its ability to dissociate and accept an H+ ion. Most ៝ 1 2 UNIT VIII Renal Function and Fluids and Electrolytes MECHANISMS OF ACID-BASE BALANCE ៝ ➤ The pH is determined by the ratio of the bicarbonate (HCO 3−) base to the volatile carbonic acid (H2CO3 H+ + HCO3−). At a normal pH of 7.4, the ratio is 20⬊1. ➤ The pH is regulated by extracellular (carbonic acid [H2CO3]/ bicarbonate [HCO3−]) and intracellular (proteins) systems that buffer changes in pH that would otherwise occur because of the metabolic production of volatile (CO2) and nonvolatile (i.e., sulfuric and phosphoric) acids. ៝ ៝ ➤ The respiratory system regulates the concentration of the volatile carbonic acid (CO2 + H2O H2CO3 H+ + HCO3−) by changing the rate and depth of respiration. ➤ The kidneys regulate the plasma concentration of HCO 3− by two processes: reabsorption of the filtered HCO3− and generation of new HCO3− or the elimination of H+ ions that have been buffered by tubular systems (phosphate and ammonia) to maintain a luminal pH of at least 4.5. of the body’s acids and bases are weak acids and bases; the most important are carbonic acid (H2CO3), which is a weak acid derived from carbon dioxide (CO2), and bicarbonate (HCO3−), which is a weak base. The concentration of the H+ ion in body fluids is low compared with other ions. For example, the sodium ion (Na+) is present at a concentration approximately 1 million times that of the H+ ion. Because of its low concentration in body fluids, the H+ ion is commonly expressed in terms of pH. Specifically, pH represents the negative logarithm (p) of the H+ ion concentration in milliequivalents per liter; a pH value of 7.0 implies an H+ ion concentration of 10−7 (0.0000001) equivalents per liter (mEq/L). The pH is inversely related to the H+ ion concentration; a low pH indicates a high concentration of H+ ions, and a high pH indicates a low concentration of H+ ions. The dissociation constant (K) is used to describe the degree to which an acid or base dissociates. The symbol pKa refers to the negative logarithm of the dissociation constant for an acid and represents the pH at which the acid is 50% dissociated.1 Use of a negative logarithm for the dissociation constant allows pH to be expressed as a positive value. Each acid in an aqueous solution has a characteristic pKa that varies slightly with temperature and pH. At normal body temperature, the pKa for the HCO3− buffer system of the extracellular fluid compartment is 6.1. METABOLIC ACID AND BICARBONATE PRODUCTION Acids are continuously generated as byproducts of metabolic processes. Physiologically, these acids fall into two groups: the volatile acid H2CO3 and all other nonvolatile or fixed acids. The difference between the two types of acids arises because H2CO3 is in equilibrium with the volatile gas CO2, which leaves the body by way of the lungs (Fig. 34-1). The concentration of H2CO3 is therefore determined by the lungs and their respiratory capacity. The fixed acids (e.g., sulfuric, hydrochloric, phosphoric) are nonvolatile and are not eliminated by the lungs. Instead, they are buffered by body proteins or extracellular buffers, such as HCO3−, and then excreted by the kidney. Carbon Dioxide and Bicarbonate Production Body metabolism results in the production of approximately 15,000 mmol of CO2 each day.1 Carbon dioxide is transported in the circulation in three forms: attached to hemoglobin, as dissolved CO2 in the plasma, and as HCO3− (Fig. 34-2). Collectively, dissolved CO2 and HCO3− constitute approximately 77% of the CO2 that is transported in the extracellular fluid; the remaining CO2 travels attached to hemoglobin.2 Although CO2 is not an acid, a small percentage of the gas combines with water in the bloodstream to form H2CO3. The reaction that generates H2CO3 from CO2 and water is catalyzed by an enzyme called carbonic anhydrase, which is present in large quantities in red blood cells, renal tubular cells, and other tissues in the body. The rate of the reaction between CO2 and water is increased approximately 5000 times by the presence of carbonic anhydrase. Were it not for this enzyme, the reaction would occur too slowly to be of any significance. Because it is almost impossible to measure H2CO3, dissolved CO2 measurements are commonly substituted when calculating pH. The H2CO3 content of the blood can be calculated by multiplying the partial pressure of CO2 (PCO2) by its solubility coefficient, which is 0.03. This means that the concentration of H2CO3 in arterial blood, which normally has a PCO2 of approximately 40 mm Hg, is 1.2 mEq/L (40 × 0.03 = 1.2). Production of Noncarbonic Acids and Bases The metabolism of dietary proteins and other substances results in the generation of noncarbonic acids and bases.1 Oxidation of the sulfur-containing amino acids (e.g., methionine, cysteine, cystine) results in the production of sulfuric acid. Oxidation of arginine and lysine produces hydrochloric acid, and oxidation of phosphorus-containing nucleic acids yields phosphoric acid. Incomplete oxidation of glucose results in the formation of lactic acid, and incomplete oxidation of fats results in the production of ketoacids. The major source of base is the metabolism of amino acids such as aspartate and glutamate and the metabolism of certain organic anions (e.g., citrate, lactate, acetate). Acid production normally exceeds base production, with the net effect being the addition of approximately 1 mmol/kg body weight of nonvolatile or fixed acid to the body each day.1 A vegetarian diet, which contains large amounts of organic anions, results in the net production of base. CHAPTER 34 Disorders of Acid-Base Balance 3 Food intake Digestion Absorption Cell metabolism of foodstuffs Intracellular and extracellular buffering Renal buffering Respiratory buffering CO2 CO2 H2CO3 Nonvolatile acids Proteins and bicarbonate Excreted (combined with urinary buffer bases) Nonvolatile acids FIGURE 34-1 The role of intracellular and extracellular buffer, respiratory, and renal mechanisms in maintaining normal blood pH. (Rhoades R. A., Tanner G. A. [1996]. Medical physiology [p. 468]. Boston: Little, Brown) CALCULATION OF pH Tissue cell Red blood cell H2O Hgb CO2 H2CO3 H2O CA Hgb + CO2 CO2 CO2 HCO3- H+ + Hgb HHgb HCO3- Cl- CO2 Carbon dioxide (CO2) is transported as: dissolved CO2 hemoglobin (Hgb) bicarbonate (HCO -) FIGURE 34-2 Mechanisms of carbon dioxide transport. CA, carbonic anhydrase 3 The plasma pH can be calculated using an equation called the Henderson-Hasselbalch equation. This equation uses the negative logarithm of the dissociation constant and the logarithm of the HCO3− to CO2 (HCO3−/CO2) ratio to calculate pH: pH = pKa (6.1) + log10 HCO3−/(0.03 × CO2). It should be noted that it is the ratio rather than the absolute values for bicarbonate and dissolved CO2 that determines pH (e.g., when the ratio is 20⬊1, pH = 7.4). Plasma pH decreases when the ratio is less than 20:1, and it increases when the ratio is greater than 20⬊1 (Fig. 34-3). Because it is the ratio rather than the absolute values of HCO3− or CO2 that determines pH, the pH can remain within relatively normal values as long as changes in HCO3− are accompanied by similar changes in CO2, or vice versa. For example, the pH will remain at 7.4 when plasma HCO3− has increased from 24 to 48 mEq/L as long as CO2 4 UNIT VIII Renal Function and Fluids and Electrolytes FIGURE 34-3 Normal and compensated states of pH and acid-base balance represented as a balance scale. (A) When the ratio of bicarbonate (HCO3−) to carbonic acid (H2CO3, arterial CO2 × .03) = 20⬊1, the pH = 7.4. (B) Metabolic acidosis with an HCO3−⬊H3CO3 ratio of 10⬊1 and a pH of 7.1. (C) Respiratory compensation lowers the H3CO3 to 0.6 mEq/L and returns the HCO3−⬊H3CO3 ratio to 20⬊1 and the pH to 7.4. (D) Respiratory alkalosis with an HCO3−⬊H3CO3 ratio of 40⬊1 and a pH of 7.7. (E) Renal compensation eliminates HCO3−, reducing serum levels to 12 mEq/L, returning the HCO3−⬊H3CO3 ratio to 20⬊1 and the pH to 7.4. Normally, these compensatory mechanisms are capable of buffering large changes in pH, but do not return the pH completely to normal, as illustrated here. levels are also doubled (see Fig. 34-3). Likewise, the pH will remain at 7.4 when plasma HCO3− has decreased from 24 to 12 mEq/L as long as CO2 levels are reduced by one half. REGULATION OF pH The pH of body fluids is regulated by intracellular and extracellular buffering systems that prevent large changes in the extracellular pH from occurring through respiratory mechanisms that eliminate CO2 and by renal mech- anisms that conserve HCO3− ions and eliminate H+ ions (see Fig. 34-1). The pH is further influenced by the electrolyte composition of the intracellular and extracellular compartments. Intracellular and Extracellular Buffer Systems The moment-by-moment regulation of pH depends on intracellular and extracellular buffer systems. A buffer system consists of a weak acid and the base salt of that acid or of a weak base and its acid salt. In the process of preventing CHAPTER 34 large changes in pH, the system trades a strong acid for a weak acid or a strong base for a weak base. The two major buffer systems that protect the pH of body fluids are proteins and the bicarbonate buffer system.3,4 These buffer systems are immediately available to combine with excess acids or bases and prevent large changes in pH from occurring during the time it takes for respiratory and renal mechanisms to become effective. Bone also represents an important site for buffering of acids and bases.3 Although it is difficult to measure, it has been estimated that 40% of acute acid-base buffering occurs in bone.1 The role of bone buffers is even higher in chronic acid-base disorders. One consequence of bone buffering is the release of calcium from bone and increased renal excretion of calcium. In addition to causing demineralization of bone, it also predisposes to kidney stones. Protein Buffer Systems. Proteins are the largest buffer system in the body. Proteins are amphoteric, meaning that they can function as acids or bases. They contain many ionizable groups that can release or bind H+. The protein buffers are largely located in cells, and H+ ions and CO2 diffuse across cell membranes for buffering by intracellular proteins. Albumin and plasma globulins are the major protein buffers in the vascular compartment. Bicarbonate Buffer System. The bicarbonate buffer system uses H2CO3 as its weak acid and a bicarbonate salt such as sodium bicarbonate (NaHCO3) as its weak base. It substitutes the weak H2CO3 for a strong acid such as hydrochloric acid (HCl + NaHCO3 H2CO3 + NaCl) or the weak bicarbonate base for a strong base such as sodium hydroxide (NaOH + H2CO3 NaHCO3 + H2O). The HCO3−/CO2 buffer system is a particularly efficient system because the buffer components can be readily added or removed from the body.2,5 Metabolism provides an ample supply of CO2, which can replace any H2CO3 that is lost when excess base is added, and CO2 can be readily eliminated when excess acid is added. Likewise, the kidney can conserve or form new HCO3− when excess acid is added, and it can excrete HCO3− when excess base is added. ៝ ៝ Disorders of Acid-Base Balance 5 Respiratory Control Mechanisms The second line of defense against acid-base disturbances is the control of CO2 by the respiratory system. Excess CO2 or excess H+ ions in the blood mainly act directly on the respiratory center in the brain to control ventilation. Although H+ ions do not easily cross the blood–brain barrier, CO2 crosses with ease and in the process reacts with water to form carbonic acid, which dissociates into H+ and HCO3− ions. It is the H+ ion that stimulates the respiratory center, causing an increase or decrease in ventilation. The respiratory control of pH is rapid, occurring within minutes, and is maximal within 12 to 24 hours.1 Although the respiratory response is rapid, it does not completely return the pH to normal. It is only about 50% to 75% effective as a buffer system. This means that if the pH falls from 7.4 to 7.0, the respiratory system can return the pH to a value of about 7.2 to 7.3.2 In acting rapidly, however, it prevents large changes in pH from occurring while waiting for the much more slowly reacting kidneys to respond. Although CO2 readily crosses the blood–brain barrier, there is a lag for entry of the HCO3− ion. Thus, blood pH and HCO3− levels drop more rapidly than cerebrospinal fluid (CSF) levels. In metabolic acidosis, for example, in which there is a primary decrease in HCO3− ions, there is often a 12- to 24-hour delay in maximal respiratory response.1 Likewise, when metabolic acid-base disorders are corrected rapidly, the respiratory response may persist because of a delay in CSF adjustments. Renal Control Mechanisms The kidneys regulate acid-base balance by excreting either an acidic or an alkaline urine. Excreting an acidic urine reduces the amount of acid in the extracellular fluid, and excreting an alkaline urine removes base from the extracellular fluid. The renal mechanisms for regulating acid-base balance cannot adjust the pH within minutes, as respiratory mechanisms can, but they continue to function for days until the pH has returned to normal or near-normal range. Plasma Potassium–Hydrogen Exchange. Potassium ions Hydrogen Ion Elimination and Bicarbonate Conservation. The kidney regulates pH by excreting excess H+ ions (K+) and H+ ions interact in important ways in the regulation of acid-base balance. Both ions are positively charged, and both ions move freely between the intracellular and extracellular compartments. In situations of acidosis, excess H+ ions move into the intracellular compartment for buffering. When this happens, another cation, in this case the K+ ion, must leave the cell and move into the extracellular fluid. When extracellular potassium levels fall, K+ ions move out of the cell and are replaced by H+ ions. Thus, alterations in extracellular potassium levels can affect acidbase balance, and changes in acid-base balance can influence extracellular potassium levels. Potassium shifts tend to be more pronounced in metabolic acidosis than respiratory acidosis.5,6 Also, metabolic acidosis caused by an accumulation of nonorganic acids (e.g., HCl that occurs in diarrhea, phosphoric acid that occurs in renal failure) produces a greater increase in extracellular potassium than does acidosis caused by an accumulation of organic acids (e.g., lactic acid, ketoacids). and reabsorbing or regenerating HCO3− ions. Bicarbonate is freely filtered in the glomerulus (approximately 4500 mEq/ day) and reabsorbed in the tubules.5 Loss of even small amounts of HCO3− impairs the body’s ability to buffer its daily load of metabolic acids. Because H+ ions are not filtered in adequate amounts to maintain acid-base balance, they are secreted from blood in the peritubular capillaries into the urine filtrate in the renal tubules. Most of the H+ ion secretion and reabsorption of HCO3− ions takes place in the proximal tubule. The process begins with a coupled Na+/H+ transport system in which a H+ ion is secreted into the tubular fluid and a Na+ ion is reabsorbed into the tubular cell (Fig. 34-4). The secreted H+ ion combines with a filtered HCO3− ion to yield CO2 and H2O. The water is eliminated in the urine, and the CO2 diffuses into the tubular cell, where it combines with water, in a carbonic anhydrase–mediated reaction to form a HCO3− ion and a H+ ion. The HCO3− ion is then reabsorbed into the blood along with the Na+ ion, and the newly generated H+ 6 UNIT VIII Tubular lumen (Urine filtrate) Renal Function and Fluids and Electrolytes Tubular cell Peritubular capillary (Extracellular fluid) Tubular lumen (Urine filtrate) Tubular cell Peritubular capillary (Extracellular fluid) HCO3- + Na + Na+ H+ H2CO 3 CA H2 O + CO2 Na+ H ++ HCO 3H2CO3 CA H2O + CO 2 Na+ ATP K+ NaHPO4- + Na + H+ Na+ H + HCO 3- H2CO 3 CO2 NaH 2PO4 H2O + CO 2 CA ATP K+ HCO 3CO2 FIGURE 34-4 Hydrogen ion (H+) secretion and bicarbonate ion (HCO3−) reabsorption in a renal tubular cell. Carbon dioxide (CO2) diffuses from the blood or urine filtrate into the tubular cell, where it combines with water in a carbonic anhydrase-catalyzed reaction that yields carbonic acid (H2CO3). The H2CO3 dissociates to form H+ and HCO3−. The H+ is secreted into the tubular fluid in exchange for Na+. The Na+ and HCO3− enter the extracellular fluid. FIGURE 34-5 The renal phosphate buffer system. The monohydrogen phosphate ion (HPO42−) enters the renal tubular fluid in the glomerulus. A H+ combines with the HPO42− to form H2PO4− and is then excreted into the urine in combination with Na+. The HCO3− moves into the extracellular fluid along with the Na+ that was exchanged during secretion of the H+. ion is secreted into the tubular fluid to begin another cycle. Normally, only a few of the secreted H+ ions remain in the tubular fluid because the secretion of H+ ions is roughly equivalent to the number of HCO3− ions that are filtered in the glomerulus. H+ ions by NH3 in the collecting tubules.1,2 The metabolism of glutamate in the proximal tubule results in the formation of two NH4+ and two HCO3− ions (Fig. 34-6A). The two NH4+ ions are secreted into the tubular fluid by a countertransport mechanism in exchange for a Na+ ion. The two HCO3− ions move out of the tubular cell along with the reabsorbed Na+ ion to enter the peritubular capillaries system. Thus, for each molecule of glutamine metabolized in the proximal tubule, two NH4+ ions are secreted into the tubular filtrate, and two HCO3− ions are reabsorbed into the blood. The HCO3− generated by this process constitutes new HCO3−. A second buffering mechanism involves the recycling of NH4+ by tubular cells in the medullary portion of the kidney. Here, NH4+ is converted to NH3 and secreted into the tubular lumen. In the collecting tubules, H+ ions that are secreted into the tubular lumen combine with NH3 to form NH4+ ions (see Fig. 34-6B). However, this part of the tubule is relatively impermeable to NH4+; therefore, once the H+ has reacted with NH3 to NH4+, it becomes trapped in the tubular lumen and is eliminated in the urine. In the process of being converted to NH3, the H+ from the recycled NH4+ promotes the reabsorption of HCO3− by combining with HCO3− delivered from the proximal tubule. Thus, an additional new HCO3− is generated and added to the blood for each NH4+ that is recycled. One of the most important features of the ammonia buffer system is that it is subject to physiologic control. Under normal conditions, the amount of H+ ion eliminated by the ammonia buffer system is about 50% of the acid excreted and new HCO3− regenerated. However, with chronic acidosis, it can become the dominant mechanism for H+ excretion and new HCO3− generation. Tubular Buffer Systems. Because an extremely acidic urine would be damaging to structures in the urinary tract, the pH of the urine is maintained within a range from 4.5 to 8.0. This limits the number of unbuffered H+ ions that can be excreted by the kidney. When the number of free H+ ions secreted into the tubular fluid threatens to cause the pH of the urine to become too acidic, they must be carried in some other form. This is accomplished by combining H+ ions with intratubular buffers before they are excreted in the urine. There are two important intratubular buffer systems: the phosphate buffer system and the ammonia buffer system. The phosphate buffer system uses HPO42− and H2PO4− that are present in the tubular filtrate. Both become concentrated in the tubular fluid because of their relatively poor absorption and because of reabsorption of water from the tubular fluid. The combination of H+ with HPO42− to form H2PO4− allows the kidneys to increase their secretion of H+ ions (Fig. 34-5). Another important but more complex buffer system is the ammonia buffer system. The excretion of H+ and generation of HCO3− by the ammonia buffer system occurs in three major steps: (1) the synthesis of ammonium (NH4+) from the amino acid glutamine in the proximal tubule, thick ascending loop of Henle, and distal tubules; (2) the reabsorption and recycling of NH3 within the medullary portion of the kidney; and (3) the buffering of CHAPTER 34 Disorders of Acid-Base Balance 7 FIGURE 34-6 The ammonia buffer systems. (A) In the proximal, ascending loop of Henle, and distal tubule, two ammonium (NH4+) ions and two bicarbonate (HCO3−) ions are synthesized from the amino acid glutamine. The two NH4+ are secreted into the tubular fluid in exchange for a two sodium (Na+) ions and are either eliminated in the urine as ammonium chloride (NH4+Cl) or recycled in the medullary nephrons. The two HCO3− ions, which represent new HCO3− are returned to the circulation. (B) A second NH4+ exchange system occurs in the collecting tubules where secreted hydrogen (H+) ions combine with ammonia (NH3) from recycled NH4+ and are then eliminated in the urine as NH4+Cl. Hydrogen and Potassium Ions Compete for Elimination in the Urine. Plasma K+ levels influence renal elimination of H+ ions, and vice versa. When plasma K+ levels fall, there is movement of K+ ions from body cells into the extracellular fluid and a reciprocal movement of H+ ions from the extracellular fluid into body cells. In the kidney, these movements lower the intracellular pH of tubular cells, causing an increase in H+ ion secretion. Potassium depletion also stimulates ammonia synthesis by the kidney as a means of buffering the excess H+ ions. The net result is an increased reabsorption of the filtered HCO3− ions and the development of metabolic alkalosis. An elevation in plasma K+ levels has the opposite effect. Plasma K+ levels are similarly altered by acid-base balance. Acidosis tends to increase H+ ion elimination and decrease K+ ion elimination, with a resultant increase in plasma potassium levels. Alkalosis has the opposite effect. Aldosterone also influences H+ ion elimination by the kidney. It acts in the collecting duct to stimulate H+ ion secretion indirectly, while increasing Na+ ion reabsorption and K+ ion secretion (see Chapter 32). Hyperaldosteronism tends to lead to a decrease in plasma K+ levels and increased pH and alkalosis because of increased H+ ion secretion. Hypoaldosteronism has the opposite effect. It leads to increased K+ levels, decreased H+ ion secretion, and acidosis. Influence of Sodium Chloride–Bicarbonate Exchange on pH. Body sodium levels can indirectly influence acid-base balance by way of the Cl−/HCO3− exchange system. Sodium reabsorption in the kidneys requires the reabsorption of an accompanying anion. The two major anions in the extracellular fluid are Cl− and HCO3−. Renal Function and Fluids and Electrolytes Base excess or deficit measures the level of all the buffer systems of the blood—hemoglobin, protein, phosphate, and HCO3−. The base excess or deficit describes the amount of a fixed acid or base that must be added to a blood sample to achieve a pH of 7.4 (normal ± 3.0 mEq/L).1 For practical purposes, base excess or deficit is a measurement of bicarbonate excess or deficit. Base excess indicates metabolic alkalosis, and base deficit indicates metabolic acidosis. regulation of acid-base balance. The pH of the extracellular fluid is normally maintained within the narrow physiologic range of 7.35 to 7.45. Metabolic processes produce volatile and fixed or nonvolatile metabolic acids that must be buffered and eliminated from the body. The volatile acid, H2CO3, is in equilibrium with dissolved CO2, which is eliminated through mEq Normal 140 130 120 110 100 Acidosis due to excess organic acids Acidosis due to excess chloride levels Anion gap 12 mEq/L 150 Sodium 142 mEq/L Base Excess or Deficit In summary, normal body function depends on the precise Chloride 116 mEq/L Bicarbonate 14 mEq/L The PCO2 of the arterial blood gases provides a means of assessing the respiratory component of acid-base balance. Arterial blood gases are used because venous blood gases are highly variable, depending on metabolic demands of the various tissues that empty into the vein from where the sample is being drawn. The dissolved CO2 levels can be determined from arterial blood gas measurements using the PCO2 and the solubility coefficient for CO2 (normal arterial PCO2 is 38 to 42 mm Hg). Arterial blood gases also provide a measure of blood oxygen (PO2) levels. This can be important in assessing respiratory function. Laboratory tests include measurements of the CO2 content and HCO3− in the blood. The CO2 content that is included in these measurements is different from the PCO2 that is measured in blood gases. Instead, it refers to the total CO2 content of blood, including that contained in HCO3−. More than 70% of the CO2 in the blood is in the form of bicarbonate. The CO2 content is determined by adding a strong acid to a plasma sample and measuring the amount of CO2 generated. The plasma HCO3− concentration is then determined from the total CO2 content of the blood. The normal range of values for venous HCO3− concentration is 24 to 29 mEq/L (24 to 29 mmol/L). Anion gap 25 mEq/L Carbon Dioxide and Bicarbonate Levels Chloride 103 mEq/L Bicarbonate 14 mEq/L Laboratory tests that are used in assessing acid-base balance include those for arterial blood gases and pH, CO2 content and HCO3− levels, base excess or deficit, and the anion gap. Although useful in determining whether acidosis or alkalosis is present, the pH of the blood as measured by a pH meter or electrode provides little information about the cause of an acid-base disorder. The anion gap describes the difference between the plasma concentration of the major measured cation (Na+) and the sum of the measured anions (Cl− and HCO3−). This difference represents the concentration of unmeasured anions, such as phosphates, sulfates, organic acids, and proteins (Fig. 34-7). Normally, the anion gap ranges between 8 and 12 mEq/L (a value of 16 mEq/L is normal if both sodium and potassium concentrations are used in the calculation). The anion gap is increased in conditions such as lactic acidosis and ketoacidosis that result from elevated levels of metabolic acids. A low anion gap is found in conditions that produce a fall in unmeasured anions (primarily albumin) or rise in unmeasured cations. The latter can occur in hyperkalemia, hypercalcemia, hypermagnesemia, lithium intoxication, or multiple myeloma, in which an abnormal immunoglobulin is produced.1 The anion gap of urine can also be measured. It uses values for the measurable cations (Na+ and K+) and measurable anion (Cl−) to provide an estimate of ammonium (NH4+) excretion. Because ammonium is a cation, the value of the anion gap becomes more negative as the ammonium level increases. In normal persons secreting 20 to 40 mmol of ammonium per liter, the urine anion gap is close to zero. In metabolic acidosis, the amount of unmeasurable NH4+ should increase if renal excretion of H+ is intact; as a result, the urine anion gap should become more negative. Sodium 142 mEq/L LABORATORY TESTS Anion Gap Anion gap 12 mEq/L One of the mechanisms that the kidneys use in regulating the pH of the extracellular fluids is to conserve or eliminate HCO3− ions; in the process, it often is necessary to shuffle anions. Chloride is the most abundant anion in the extracellular fluid and can substitute for HCO3− when an anion shift is needed. As an example, plasma HCO3− levels normally increase as hydrochloric acid is secreted into the stomach after a heavy meal, causing what is called the postprandial alkaline tide. Later, as the Cl− is reabsorbed in the small intestine, the pH returns to normal. Hypochloremic alkalosis refers to an increase in pH that is induced by a decrease in plasma Cl− levels. Hyperchloremic acidosis occurs when excess levels of Cl− are present. Sodium 142 mEq/L UNIT VIII Chloride 103 mEq/L Bicarbonate 27 mEq/L 8 FIGURE 34-7 The anion gap in acidosis due to excess metabolic acids and excess plasma chloride levels. Unmeasured anions such as phosphates, sulfates, and organic acids increase the anion gap because they replace bicarbonate. This assumes there is no change in sodium content. CHAPTER 34 the lungs. The nonvolatile metabolic acids, most of which are excreted by the kidneys, are derived mainly from protein metabolism and incomplete carbohydrate and fat metabolism. It is the ratio of the HCO3− ion concentration to dissolved CO2 (H2CO3 concentration) that determines body pH. When this ratio is 20⬊1, the pH is 7.4. The ability of the body to maintain pH within the normal physiologic range depends on intracellular and extracellular mechanisms for buffering excess H+ and HCO3− ions and on the respiratory and renal mechanisms for eliminating or conserving excess acids and bases. Proteins are the most important intracellular buffers, and the HCO3− buffer system includes the most important extracellular buffers. The respiratory system contributes to the regulation of pH by controlling the elimination of CO2. The kidney aids in regulation of pH by eliminating H+ ions or conserving HCO3− ions. In the process of eliminating H+ ions, it uses the phosphate and ammonia buffer systems. Body pH is also affected by the distribution of exchangeable cations (K+ and H+) and anions (Cl− and HCO3−). Laboratory tests that are used in assessing acid-base balance include arterial blood gas measurements, CO2 content and HCO3− levels, base excess or deficit, and the anion gap. The base excess or deficit describes the amount of a fixed acid or base that must be added to a blood sample to achieve a pH of 7.4. The anion gap describes the difference between the plasma concentration of the major measured cation (Na+) and the sum of the measured anions (Cl− and HCO3−). This difference represents the concentration of unmeasured anions, such as phosphates, sulfates, organic acids, and proteins, that are present. Disorders of Acid-Base Balance After you have completed this section of the chapter, you should be able to meet the following objectives: ✦ Differentiate the terms acidemia, alkalemia, acidosis, and alkalosis ✦ Describe a clinical situation involving an acid-base 9 ✦ Explain the use of the plasma anion gap in differentiating types of metabolic acidosis ✦ List common causes of metabolic and respiratory acidosis and metabolic and respiratory alkalosis ✦ Contrast and compare the clinical manifestations and treatment of metabolic and respiratory acidosis and of metabolic and respiratory alkalosis The terms acidosis and alkalosis describe the clinical conditions that arise as a result of changes in dissolved CO2 and HCO3− concentrations. An alkali represents a combination of one or more alkali metals such as sodium or potassium with a highly basic ion such as a hydroxyl ion (OH−). Sodium bicarbonate is the main alkali in the extracellular fluid. Although the definitions differ somewhat, the terms alkali and base are often used interchangeably. Hence, the term alkalosis has come to mean the opposite of acidosis. METABOLIC VERSUS RESPIRATORY ACID-BASE DISORDERS There are two types of acid-base disorders: metabolic and respiratory (Table 34-1). Metabolic disorders produce an alteration in bicarbonate concentration and result from the addition or loss of nonvolatile acid or alkali to or from the extracellular fluid. A reduction in pH due to a decrease in HCO3− is called metabolic acidosis, and an elevated pH due to increased HCO3− levels is called metabolic alkalosis. Respiratory disorders involve an alteration in the PCO2, reflecting an increase or decrease in alveolar ventilation. Respiratory acidosis is characterized by a decrease in pH, reflecting a decrease in ventilation and an increase in PCO2. Respiratory alkalosis involves an increase in pH, resulting from an increase in alveolar ventilation and a decrease in PCO2. PRIMARY VERSUS COMPENSATORY MECHANISMS Acidosis and alkalosis typically involve a primary or initiating event and a compensatory or adaptive state that results from homeostatic mechanisms that attempt to correct or prevent large changes in pH. For example, a person may have a primary metabolic acidosis as a result of overproduction of disorder in which primary and compensatory mechanisms might be active ✦ Define metabolic acidosis, metabolic alkalosis, respiratory acidosis, and respiratory alkalosis TABLE 34-1 Disorders of Acid-Base Balance Summary of Acid-Base Imbalances Acid-Base Imbalance Primary Disturbance Respiratory Compensation Renal Compensation Metabolic acidosis Decrease in bicarbonate Metabolic alkalosis Increase in bicarbonate Respiratory acidosis Increase in PCO2 Hyperventilation to decrease PCO2 Hypoventilation to increase PCO2 None Respiratory alkalosis Decrease in PCO2 None If no renal disease, increased H+ excretion and increased HCO3− reabsorption If no renal disease, decreased H+ excretion and decreased HCO3− reabsorption Increased H+ excretion and increased HCO3− reabsorption Decreased H+ excretion and decreased HCO3− reabsorption 10 UNIT VIII Renal Function and Fluids and Electrolytes ketoacids and respiratory alkalosis because of a compensatory increase in ventilation (see Table 34-1). Compensatory mechanisms adjust the pH toward a more normal level without correcting the underlying cause of the disorder (see Fig. 34-3). A mixed acid-base disorder is one in which there is both a primary and a compensatory change in acid-base balance. The respiratory mechanisms, which compensate by increasing or decreasing ventilation, are rapid but seldom able to return the pH to normal because as the pH returns toward normal, the respiratory stimulus is lost. The kidneys compensate by conserving HCO3− or H+ ions. It normally takes longer to recruit renal compensatory mechanisms than it does respiratory compensatory mechanisms. Renal mechanisms are more efficient, however, because they continue to operate until the pH has returned to a normal or near-normal value. Compensatory mechanisms provide a means to control pH when correction is impossible or cannot be immediately achieved. Often, compensatory mechanisms are interim measures that permit survival while the body attempts to correct the primary disorder. Compensation requires the use of mechanisms that are different from those that caused the primary disorder. In other words, the lungs cannot compensate for respiratory acidosis that is caused by lung disease, nor can the kidneys compensate for metabolic acidosis that occurs because of renal failure. The body can, however, use renal mechanisms to compensate for respiratory-induced changes in pH, and it can use respiratory mechanisms to compensate for metabolically induced changes in acid-base balance. Because compensatory mechanisms become more effective with time, there are often differences between the level of pH change that is present in acute and chronic acid-base disorders. METABOLIC ACIDOSIS Metabolic acidosis involves a primary deficit in base HCO3− along with a decrease in plasma pH. In metabolic acidosis, the body compensates for the decrease in pH by increasing the respiratory rate in an effort to decrease CO2 and H2CO3 levels. The PCO2 can be expected to fall by 1 to 1.5 mm Hg for each 1 mEq/L fall in HCO3−.3,4 Causes Metabolic acidosis can be caused by one of four mechanisms: increased production of nonvolatile metabolic acids, decreased acid secretion by the kidney, excessive loss of bicarbonate, or an increase in Cl−.7–9 The anion gap is often useful in determining the cause of the metabolic acidosis (Chart 34-1). The presence of excess metabolic acids produces an increase in the anion gap as sodium bicarbonate is replaced by the sodium salt of the offending acid (e.g., sodium lactate). When acidosis results from increased chloride levels (e.g., hyperchloremic acidosis), the anion gap remains within normal levels. The causes of metabolic acidosis are summarized in Table 34-2. Increased Production of Metabolic Acids. Metabolic acids increase when there is an accumulation of lactic acid, overproduction of ketoacids, or drug or chemical anion ingestion. METABOLIC ACID-BASE IMBALANCE ➤ Metabolic acid-base disorders represent a primary change in the plasma HCO3− ion concentration. ➤ Metabolic acidosis can be defined as a decrease in plasma HCO3− and a pH that is caused by an excess of production or accumulation of fixed acids or loss of HCO3− ion. Compensatory responses include an increase in ventilation and elimination of CO2 and the reabsorption and generation of bicarbonate by the kidney. ➤ Metabolic alkalosis can be defined as an increase in plasma HCO3− and pH that is initiated by excess H+ ion loss or HCO3− ion gain and maintained by conditions that impair the ability of the kidney to excrete the excess HCO3− ion. Compensatory responses include a decreased respiratory rate with retention of PCO2 and increased elimination of HCO3− by the kidney. Lactic Acidosis. Acute lactic acidosis is one of the most com- mon types of metabolic acidosis.8 Lactic acidosis develops when there is excess production of lactic acid or diminished lactic acid removal from the blood. Lactic acid is produced by the anaerobic metabolism of glucose. Virtually all tissues can produce lactic acid under appropriate cir- CHART 34-1 The Anion Gap in Differential Diagnosis of Metabolic Acidosis Decreased Anion Gap (<8 mEq/L) Hypoalbuminemia (decrease in unmeasured anions) Multiple myeloma (increase in unmeasured cationic IgG paraproteins) Increased unmeasured cations (hyperkalemia, hypercalcemia, hypermagnesemia, lithium intoxication) Increased Anion Gap (>12 mEq/L) Presence of unmeasured metabolic anion Diabetic ketoacidosis Alcoholic ketoacidosis Lactic acidosis Starvation Renal insufficiency Presence of drug or chemical anion Salicylate poisoning Methanol poisoning Ethylene glycol poisoning Normal Anion Gap (8–12 mEq/L) Loss of bicarbonate Diarrhea Pancreatic fluid loss Ileostomy (unadapted) Chloride retention Renal tubular acidosis Ileal loop bladder Parenteral nutrition (arginine and lysine) CHAPTER 34 TABLE 34-2 Disorders of Acid-Base Balance 11 Metabolic Acidosis Causes Manifestations Excess Metabolic Acids (Increased Anion Gap) Excessive production of metabolic acids Lactic acidosis Diabetic ketoacidosis Alcoholic ketoacidosis Fasting and starvation Poisoning (e.g., salicylate, methanol, ethylene glycol) Impaired elimination of metabolic acids Kidney failure or dysfunction Blood pH, HCO3−, CO2 pH decreased HCO3− (primary) decreased PCO2 (compensatory) decreased Excessive Bicarbonate Loss (Normal Anion Gap) Loss of intestinal secretions Diarrhea Intestinal suction Intestinal or biliary fistula Increased renal losses Renal tubular acidosis Treatment with carbonic anhydrase inhibitors Hypoaldosteronism Increased Chloride Levels (Normal Anion Gap) Excessive reabsorption of chloride by the kidney Sodium chloride infusions Treatment with ammonium chloride Parenteral hyperalimentation Gastrointestinal Function Anorexia Nausea and vomiting Abdominal pain Neural Function Weakness Lethargy General malaise Confusion Stupor Coma Depression of vital functions Cardiovascular Function Peripheral vasodilation Decreased heart rate Cardiac dysrhythmias Skin Warm and flushed Skeletal System Bone disease (e.g., chronic acidosis) Signs of Compensation Increased rate and depth of respiration (i.e., Kussmaul breathing) Hyperkalemia Acid urine Increased ammonia in urine cumstances. Tissues such as red blood cells, intestine, and skeletal muscle do so under normal conditions. Excess lactate is produced with vigorous exercise, during which there is a local disproportion between oxygen supply and demand in the contracting muscles. The liver and, to a lesser extent, the kidney normally remove lactic acid from the blood and use it for energy or convert it back to glucose. Most cases of lactic acidosis are caused by inadequate oxygen delivery, as in shock or cardiac arrest.8 Such conditions increase lactic acid production, and they impair lactic acid clearance because of poor liver perfusion. Mortality rates are high for persons with lactic acidosis because of shock and tissue hypoxia.8 Lactic acidosis is also associated with disorders in which tissue hypoxia does not appear to be present. It has been reported in patients with leukemia, lymphomas, and other cancers; those with poorly controlled diabetes; and patients with severe liver failure. Mechanisms causing lactic acidosis in these conditions are poorly understood. Some conditions, such as neoplasms, may produce local increases in tissue metabolism and lactate production or interfere with blood flow to noncancerous cells. Ethanol produces a slight elevation in lactic acid, but clinically significant lac- tic acidosis does not occur in alcohol intoxication unless other problems, such as liver failure, are present. Lactic acidosis may also occur in mitochondrial disorders that impair oxidative metabolism. Lactic acidosis occurs in genetic mitochondrial disorders that impair lactate metabolism.10,11 One of these disorders, referred to by the acronym MELAS, involves mitochondrial encephalopathy (ME), lactic acidosis (LA), and strokelike episodes (S). Children with the disorder function normally for the first few years of their lives and then begin to display impaired motor and cognitive development. The mitochondrial defect also leads to short stature, seizure disorders, and multiple strokes. Lowering the plasma lactate level of children with severe lactic acidosis may result in marked clinical improvement. A variety of drugs can also produce life-threatening lactic acidosis by inhibiting mitochondrial function. These drugs include the biguanide antidiabetic drugs and the antiretroviral nucleoside analogs that are used to treat acquired immunodeficiency syndrome (AIDS).8 A unique form of lactic acidosis, called D-lactic acidosis, can occur in persons with intestinal disorders that involve the generation and absorption of D-lactic acid (L-lactic acid is the usual cause of lactic acidosis). D-Lactic 12 UNIT VIII Renal Function and Fluids and Electrolytes acidosis can occur in persons with jejunoileal bypass, small bowel resection, or short bowel syndrome, in which there is impaired reabsorption of carbohydrate in the small intestine.8,12 In these cases, the unabsorbed carbohydrate is delivered to the colon, where it is converted to D-lactic acid by an overgrowth of gram-positive anaerobes. Persons with D-lactic acidosis experience episodic periods of metabolic acidosis often brought on by eating a meal high in carbohydrates. Manifestations include confusion, cerebellar ataxia, slurred speech, and loss of memory. They may complain of feeling (or may appear) intoxicated. Treatment includes use of antimicrobial agents to decrease the number of D-lactic acid–producing microorganisms in the bowel along with a low-carbohydrate diet. Ketoacidosis. Ketoacids (i.e., acetoacetic and β-hydroxybu- tyric acid), produced in the liver from fatty acids, are the source of fuel for many body tissues. An overproduction of ketoacids occurs when carbohydrate stores are inadequate or when the body cannot use available carbohydrates as a fuel. Under these conditions, fatty acids are mobilized from adipose tissue and delivered to the liver, where they are converted to ketones. Ketoacidosis develops when ketone production exceeds tissue use. The most common cause of ketoacidosis is uncontrolled diabetes mellitus, in which an insulin deficiency leads to the release of fatty acids from adipose cells with subsequent production of excess ketoacids (see Chapter 43). Ketoacidosis may also develop as the result of fasting or food deprivation, during which the lack of carbohydrates produces a self-limited state of ketoacidosis. The selflimited nature of ketoacidosis results from a decrease in insulin, which further suppresses the release of fatty acids from fat cells. Ketones are also formed during the oxidation of alcohol, a process that occurs in the liver. A condition called alcoholic ketoacidosis can develop in persons who engage in excess alcohol consumption.13 It usually follows prolonged alcohol ingestion, particularly if accompanied by decreased food intake and vomiting—conditions that result in using fatty acids as an energy source. The ketoacids responsible for alcoholic ketoacidosis are formed in part as a result of alcohol metabolism. Ketone formation may be further enhanced by the hypoglycemia that results from alcoholinduced inhibition of glucose synthesis (i.e., gluconeogenesis) by the liver and impaired ketone elimination by the kidneys because of dehydration. An extracellular fluid volume deficit caused by vomiting and decreased fluid intake often contributes to the acidosis. Numerous other factors, such as elevations in cortisol, growth hormone, glucagon, and catecholamines, mediate free fatty acid release and thereby contribute to the development of alcoholic ketoacidosis. Salicylate Toxicity. Salicylates are another potential source of metabolic acids. Aspirin (acetylsalicylic acid) is rapidly converted to salicylic acid in the body. Although aspirin is the most common cause of salicylate toxicity, other salicylate preparations such as methyl salicylate, sodium salicylate, and salicylic acid may be involved. Salicylate overdose produces serious toxic effects, including death. A fatal overdose can occur with as little as 10 to 30 g in adults and 3 g in children.1 A variety of acid-base disturbances occur with salicylate toxicity. The salicylates cross the blood–brain barrier and directly stimulate the respiratory center, causing hyperventilation and respiratory alkalosis. The kidneys compensate by secreting increased amounts of HCO3−, K+, and Na+, thereby contributing to the development of metabolic acidosis. Salicylates also interfere with carbohydrate metabolism, which results in increased production of metabolic acids. One of the treatments for salicylate toxicity is alkalinization of the plasma. Salicylic acid, which is a weak acid, exists in equilibrium with the alkaline salicylate anion. It is the salicylic acid that is toxic because of its ability to cross cell membranes and enter brain cells. The salicylate anion crosses membranes poorly and is less toxic. With alkalinization of the extracellular fluids, the ratio of salicylic acid to salicylate is greatly reduced. This allows salicylic acid to move out of cells into the extracellular fluid along a concentration gradient. The renal elimination of salicylates follows a similar pattern when the urine is alkalinized. Methanol and Ethylene Glycol Toxicity. Ingestion of methanol and ethylene glycol results in the production of metabolic acids and causes metabolic acidosis. Both produce an osmolar gap because of their small size and osmotic properties. Methanol (wood alcohol) is a component of shellac, varnish, deicing solutions, sterno, and other commercial products. Methanol can be absorbed through the skin or gastrointestinal tract or inhaled through the lungs. A dose as small as 30 mL can be fatal.14 In addition to metabolic acidosis, methanol produces severe optic nerve and central nervous system toxicity. Organ system damage occurs after a 24-hour period in which methanol is converted to formaldehyde and formic acid. Ethylene glycol is a solvent found in products ranging from antifreeze and deicing solutions to carpet and fabric cleaners. It tastes sweet and is intoxicating, factors that contribute to its abuse potential. A lethal dose is approximately 100 mL.15,16 It is rapidly absorbed from the intestine, making treatment with gastric lavage and syrup of ipecac ineffective. Acidosis occurs as ethylene glycol is converted to oxalic and lactic acid. Manifestations of ethylene glycol toxicity occur in three stages: neurologic symptoms ranging from drunkenness to coma, which appear during the first 12 hours; cardiorespiratory disorders such as tachycardia and pulmonary edema; and flank pain and renal failure caused by plugging of the tubules with oxalate crystals (from excess oxalic acid production).16 The enzyme alcohol dehydrogenase metabolizes methanol and ethylene glycol into toxic metabolites. This is the same enzyme that is used in the metabolism of ethanol. Because alcohol dehydrogenase has an affinity for ethanol 10 times its affinity for methanol or ethylene glycol, intravenous or oral ethanol is used as an antidote for methanol and ethylene glycol poisoning.1 Extracellular volume expansion and hemodialysis are also used. Fomepizole, with CHAPTER 34 specific indications for ethylene glycol poisoning, was recently approved by the U.S. Food and Drug Administration.15,17 In a manner similar to ethanol, it is thought to act as an inhibitor of alcohol dehydrogenase, thereby preventing the formation of the toxic ethylene glycol metabolites. Decreased Renal Function. Kidney disease is the most common cause of chronic metabolic acidosis. The kidneys normally conserve HCO3− and secrete H+ ions into the urine as a means of regulating acid-base balance. In renal failure, there is loss of glomerular and tubular function, with retention of nitrogenous wastes and metabolic acids. In a condition called renal tubular acidosis, glomerular function is normal, but the tubular secretion of H+ or reabsorption of HCO3− is abnormal (see Chapter 35). Increased Bicarbonate Losses. Increased HCO3− losses occur with the loss of bicarbonate-rich body fluids or with impaired conservation of HCO3− by the kidney. Intestinal secretions have a high HCO3− concentration. Consequently, excessive loss of HCO3− ions occur with severe diarrhea; small bowel, pancreatic, or biliary fistula drainage; ileostomy drainage; and intestinal suction. In diarrhea of microbial origin, HCO3− is also secreted into the bowel as a means of neutralizing the metabolic acids produced by the microorganisms causing the diarrhea. Creation of an ileal bladder, which is done for conditions such as neurogenic bladder or surgical removal of the bladder because of cancer, involves the implantation of the ureters into a short, isolated loop of ileum that serves as a conduit for urine collection. With this procedure, contact time between the urine and ileal bladder is normally too short for significant anion exchange, and HCO3− is lost in the urine.1 Hyperchloremic Acidosis. Hyperchloremic acidosis occurs when Cl− ion levels are increased. Because Cl− and HCO3− are anions, the HCO3− ion concentration decreases when there is an increase in Cl− ions. Hyperchloremic acidosis can occur as the result of abnormal absorption of chloride by the kidneys or as a result of treatment with chloridecontaining medications (i.e., sodium chloride, amino acid– chloride hyperalimentation solutions, and ammonium chloride). Ammonium chloride is broken down into NH4+ and Cl−. The ammonium ion is converted to urea in the liver, leaving the Cl− ion free to react with H+ to form HCl. The administration of intravenous sodium chloride or parenteral hyperalimentation solutions that contain an amino acid–chloride combination can cause acidosis in a similar manner.18 With hyperchloremic acidosis, the anion gap is within the normal range, whereas the chloride levels are increased, and bicarbonate levels are decreased. Manifestations Metabolic acidosis is characterized by an increased extracellular H+ ion concentration with a decrease in pH (<7.35) and a decrease in HCO3− levels (<24 mEq/L). Acidosis typically produces a compensatory increase in respiratory rate with a decrease in PCO2. The manifestations of metabolic acidosis fall into three categories: signs and symptoms of the disorder causing the Disorders of Acid-Base Balance 13 acidosis, changes in body function related to recruitment of compensatory mechanisms, and alterations in cardiovascular, neurologic, and musculoskeletal function resulting from the decreased pH (see Table 34-2). The signs and symptoms of metabolic acidosis usually begin to appear when the plasma HCO3− concentration falls to 20 mEq/L or less. A fall in pH to less than 7.0 to 7.10 can reduce cardiac contractility and predispose to potentially fatal cardiac dysrhythmias.1 Metabolic acidosis is seldom a primary disorder; it usually develops during the course of another disease. The manifestations of metabolic acidosis frequently are superimposed on the symptoms of the contributing health problem. With diabetic ketoacidosis, which is a common cause of metabolic acidosis, there is an increase in blood and urine glucose and a characteristic smell of ketones to the breath. In metabolic acidosis that accompanies renal failure, blood urea nitrogen levels are elevated, and other tests of renal function yield abnormal results. Manifestations related to respiratory and renal compensatory mechanisms usually occur early in the course of metabolic acidosis. In situations of acute metabolic acidosis, the respiratory system compensates for a decrease in pH by increasing ventilation to reduce PCO2; this is accomplished through deep and rapid respirations. In diabetic ketoacidosis, this breathing pattern is referred to as Kussmaul breathing. For descriptive purposes, it can be said that Kussmaul breathing resembles the hyperpnea of exercise— the person breathes as though he or she had been running. There may be complaints of difficult breathing or dyspnea with exertion; with severe acidosis, dyspnea may be present even at rest. Respiratory compensation for acute acidosis tends to be somewhat greater than for chronic acidosis. When kidney function is normal, H+ ion excretion increases promptly in response to acidosis, and the urine becomes more acid. Changes in pH have a direct effect on body function that can produce signs and symptoms common to most types of metabolic acidosis, regardless of cause. A person with metabolic acidosis often complains of weakness, fatigue, general malaise, and a dull headache. The person also may have anorexia, nausea, vomiting, and abdominal pain. Tissue turgor is impaired, and the skin is dry when fluid deficit accompanies acidosis. In persons with undiagnosed diabetes mellitus, the nausea, vomiting, and abdominal symptoms may be misinterpreted as being caused by gastrointestinal flu or other abdominal disease, such as appendicitis. Acidosis depresses neuronal excitability and decreases binding of calcium to plasma proteins so that more free calcium is available to decrease neural activity. As acidosis progresses, the level of consciousness declines, and stupor and coma develop. The skin is often warm and flushed because skin vessels become less responsive to sympathetic stimulation and lose tone. When the pH falls to 7.0 to 7.1, cardiac contractility and cardiac output decrease, the heart becomes less responsive to catecholamines (i.e., epinephrine and norepinephrine), and dysrhythmias, including fatal ventricular dysrhythmias, can develop. A decrease in ventricular function may be particularly important in perpetuating shock-induced 14 UNIT VIII Renal Function and Fluids and Electrolytes lactic acidosis, and partial correction of the acidemia may be necessary before tissue perfusion can be restored.1 Chronic acidemia, as in renal failure, can lead to a variety of musculoskeletal problems, some of which result from the release of calcium and phosphate during bone buffering of excess H+ ions.19 Of particular importance is impaired growth in children. In infants and children, acidemia may be associated with a variety of nonspecific symptoms such as anorexia, weight loss, muscle weakness, and listlessness.1,14 Muscle weakness and listlessness may result from alterations in muscle metabolism. Treatment The treatment of metabolic acidosis focuses on correcting the condition that caused the disorder and restoring the fluids and electrolytes that have been lost from the body. The treatment of diabetic ketoacidosis is discussed in Chapter 43. The use of supplemental sodium bicarbonate (NaHCO3) may be indicated in the treatment of some forms of normal anion gap acidosis. However, its use in treatment of metabolic acidosis with an increased anion gap is controversial, particularly in cases of impaired tissue perfusion.4,20 In most patients with cardiac arrest, shock, or sepsis, impaired oxygen delivery is the primary cause of lactic acidosis. In these situations, the administration of large amounts of NaHCO3 does not improve oxygen delivery and may produce hypernatremia, hyperosmolality, and decreased oxygen release by hemoglobin because of a shift in the oxygen dissociation curve.20 TABLE 34-3 METABOLIC ALKALOSIS Metabolic alkalosis is a systemic disorder caused by an increase in pH due to a primary excess of plasma HCO3− ions.21,22 It can be caused by a loss of H+ ions, net gain in HCO3− ions, or loss of Cl− ions in excess of HCO3− ions. Metabolic alkalosis is reported to be the second most common acid-base disorder in hospitalized adults, accounting for about 32% of all acid-base disorders.22 Causes Most of the body’s plasma HCO3− is obtained from three sources: from CO2 that is produced during metabolic processes, from reabsorption of filtered HCO3−, or from generation of new HCO3− by the kidney. Usually, HCO3− production and renal reabsorption are balanced in a manner that prevents alkalosis from occurring. The proximal tubule reabsorbs 99.9% of the filtered HCO3−. When the plasma levels of HCO3− rise above the threshold for tubular reabsorption, the excess is excreted in the urine. Many of the conditions that increase plasma HCO3− also raise the level for HCO3− reabsorption; thus, an increase in HCO3− contributes not only to the generation of metabolic alkalosis but also to its maintenance. Metabolic alkalosis involves both the factors that generate the loss of H+ or gain of HCO3− ions and those that maintain it by interfering with excretion of the excess HCO3− (Table 34-3). Factors that serve to maintain metabolic alkalosis include extracellular fluid volume contraction accompanied by hypokalemia and hypochloremia and mineralocorticoid (aldosterone) excess. Metabolic Alkalosis Causes Manifestations Excessive Gain of Bicarbonate or Alkali Ingestion or administration of sodium bicarbonate Administration of hyperalimentation solutions containing acetate Administration of parenteral solutions containing lactate Administration of citrate-containing blood transfusions Blood pH, HCO3−, CO2 pH increased HCO3 − (primary) increased PCO2 (compensatory) increased Excessive Loss of Hydrogen Ions Vomiting Gastric suction Binge-purge syndrome Potassium deficit Diuretic therapy Hyperaldosteronism Milk-alkali syndrome Increased Bicarbonate Retention Loss of chloride with bicarbonate retention Volume Contraction Loss of body fluids Diuretic therapy Neural Function Confusion Hyperactive reflexes Tetany Convulsions Cardiovascular Function Hypotension Dysrhythmias Respiratory Function Respiratory acidosis due to decreased respiratory rate Signs of Compensation Decreased rate and depth of respiration Increased urine pH CHAPTER 34 Excess Alkali Intake. Excessive alkali ingestion, as in the use of bicarbonate-containing antacids (e.g., AlkaSeltzer) or NaHCO3 administration during cardiopulmonary resuscitation, can cause metabolic alkalosis. Other sources of alkali intake are acetate in hyperalimentation solutions, lactate in parenteral solutions such as Ringer’s lactate, and citrate used in blood transfusions. A condition called the milk-alkali syndrome may develop in persons who consume excessive amounts of milk along with an antacid such as calcium carbonate. In this case, the carbonate raises the plasma HCO3− while the hypercalcemia prevents the excretion of excess HCO3− . The most common cause at present is the use of calcium carbonate as a phosphate buffer in persons with renal failure. Hydrogen, Chloride, and Potassium Ion Loss Associated With Bicarbonate Ion. Vomiting, removal of gastric secretions through use of nasogastric suction, and low potassium levels resulting from diuretic therapy are the most common causes of metabolic alkalosis in hospitalized patients. The binge and purge syndrome, or self-induced vomiting, also is associated with metabolic alkalosis.22 Gastric secretions contain high concentrations of HCl and lesser concentrations of potassium chloride (KCL). As Cl− is taken from the blood and secreted into the stomach with the H+ ion, it is replaced by HCO3−. Under normal conditions, each 1 mEq of H+ ion that is secreted into the stomach generates 1 mEq of plasma HCO3−.22 Because the entry of acid into the duodenum stimulates an equal amount of pancreatic HCO3− secretion, the increase in plasma HCO3− concentration is usually transient, and pH returns to normal within a matter of hours. However, loss of H+ and Cl− ions from the stomach due to vomiting or gastric suction stimulates continued production of gastric acid and thus the addition of more bicarbonate into the blood. Maintenance of Metabolic Alkalasis by Volume Contraction, Hypokalemia, and Hypochloremia. Vomiting also results in the loss of water, sodium, and potassium (Fig. 34-8). The resultant volume depletion and hypokalemia maintain the generated metabolic alkalosis by increasing the renal reabsorption of HCO3− ion. Administration of diuretics (e.g., loop and thiazide diuretics) is often associated with metabolic alkalosis. Loop diuretics decrease Na+, K+, and Cl− reabsorption, leading to volume contraction and hypokalemia. The thiazide diuretics increase renal K+ loss, leading to increased HCO3− reabsorption. Extracellular volume depletion is one of the most important factors affecting HCO3− reabsorption in the proximal tubule. A decrease in extracellular fluid volume activates the renin-angiotensin-aldosterone system, which increases Na+ reabsorption as a means of maintaining extracellular fluid volume. The reabsorption of Na+ requires concomitant anion reabsorption; because there is a Cl− deficit, HCO3− is reabsorbed along with Na+. Hypokalemia is a potent stimulus for H+ secretion and HCO3− reabsorption. The mechanisms by which hypokale- Disorders of Acid-Base Balance 15 mia increases HCO3− reabsorption are likely the effects of tubular K+/H+ ion exchange. In hypokalemia, K+ moves out of the tubular cell into the blood and is replaced by the H+ ion. This results in intracellular acidosis and increased HCO3− reabsorption. For some unknown reason, severe hypokalemia may cause a reduction in Cl− reabsorption by the distal tubule.1 As a result, Na+ reabsorption at this site is associated with greater tubular electronegativity and greater tendency to H+ secretion. It has been proposed recently that hypochloremia and the reduced delivery of Cl− to the distal tubule of the kidney are responsible for maintaining metabolic alkalosis, rather than volume depletion per se. A low intraluminal concentration of Cl− ion is interpreted by the kidney as a sign of low extracellular fluid volume, thereby serving as a stimulus for activation of the renin-angiotensin-aldosterone system. Low intraluminal concentrations of Cl− ion also reduce the driving force for bicarbonate reabsorption.22 Metabolic alkalosis can also result from excessive adrenocorticosteroid hormones (e.g., hyperaldosteronism, Cushing’s syndrome). The hormone aldosterone increases H+ ion secretion as it increases Na+ and HCO3− ion reabsorption. In hyperaldosteronism, the concurrent loss of K+ in the urine serves to perpetuate the alkalosis. Chronic respiratory acidosis produces a compensatory loss of H+ and Cl− ions in the urine along with HCO3− retention. When respiratory acidosis is corrected abruptly, as with mechanical ventilation, a “posthypercapneic” metabolic alkalosis may develop because of a rapid drop in PCO2; however, the concentration of HCO3− ions, which are eliminated renally, remains elevated. Manifestations Metabolic alkalosis is characterized by a plasma pH above 7.45, plasma HCO3− level above 29 mEq/L (29 mmol/L), and base excess above 3.0 mEq/L (3 mmol/L) (see Table 34-3). Persons with metabolic alkalosis often are asymptomatic or have signs related to volume depletion or hypokalemia. Neurologic signs and symptoms (e.g., hyperexcitability) occur less frequently with metabolic alkalosis than with other acid-base disorders because the HCO3− ion enters the CSF more slowly than CO2. When neurologic manifestations do occur, as in acute and severe metabolic alkalosis, they include mental confusion, hyperactive reflexes, tetany, and carpopedal spasm. Metabolic alkalosis also leads to a compensatory hypoventilation with development of various degrees of hypoxemia and respiratory acidosis. Significant morbidity occurs with severe metabolic alkalosis (pH >7.55), including respiratory failure, dysrhythmias, seizures, and coma. Treatment The treatment of metabolic alkalosis usually is directed toward correcting the cause of the condition. A chloride deficit requires correction. Potassium chloride usually is the treatment of choice for metabolic alkalosis when there is an accompanying K+ deficit. When KCl is used as a therapy, the Cl− anion replaces the HCO3− anion, and correcting the potassium deficit allows the kidney to conserve the 16 UNIT VIII Renal Function and Fluids and Electrolytes a sustained increase in arterial PCO2, resulting in renal adaptation and a more marked increase in plasma HCO3−.23–26 Causes Respiratory acidosis occurs in acute or chronic conditions that impair effective alveolar ventilation and cause an accumulation of PCO2 (Table 34-4). Impaired ventilation can occur as the result of decreased respiratory drive, lung disease, or disorders of chest wall and respiratory muscle. Less commonly, it results from excess CO2 production. Acute Disorders of Ventilation. Acute respiratory acidosis can be caused by impaired function of the respiratory center in the medulla (as in narcotic overdose), lung disease, chest injury, weakness of the respiratory muscles, or airway obstruction. Almost all persons with acute respiratory acidosis are hypoxemic if they are breathing room air. In many cases, signs of hypoxemia develop before those of respiratory acidosis because CO2 diffuses across the alveolar capillary membrane 20 times more rapidly than oxygen.1,2 Chronic Disorders of Ventilation. Chronic respiratory aci- FIGURE 34-8 Renal mechanisms for generating and maintaining metabolic alkalosis following depletion of extracellular fluid volume, chloride (Cl−), and potassium (K+) due to vomiting. HCO3−, bicarbonate; GFR, glomerular filtration rate. H+ ion while eliminating the K+ ion. Fluid replacement with normal saline or one half normal saline often is used in the treatment of patients with volume contraction alkalosis. RESPIRATORY ACIDOSIS Respiratory acidosis occurs in conditions that impair alveolar ventilation and cause an increase in plasma PCO2, also known as hypercapnia, along with a decrease in pH. Respiratory acidosis can occur as an acute or chronic disorder. Acute respiratory failure is associated with a rapid rise in arterial PCO2 with a minimal increase in plasma HCO3− and large decrease in pH. Chronic respiratory acidosis is characterized by dosis is a relatively common disturbance in patients with chronic obstructive lung disease (see Chapter 31). In these persons, the persistent elevation of PCO2 stimulates renal H+ ion secretion and HCO3− reabsorption. The effectiveness of these compensatory mechanisms can often return the pH to near-normal values as long as oxygen levels are maintained within a range that does not unduly suppress chemoreceptor control of respirations. An acute episode of respiratory acidosis can develop in patients with chronic lung disease who have chronically elevated PCO2 levels. This is sometimes called carbon dioxide narcosis. In these persons, the medullary respiratory center has become adapted to the elevated levels of CO2 and no longer responds to increases in PCO2. Instead, the oxygen content of their blood becomes the major stimulus for respiration. When oxygen is administered at a flow rate that suppresses this stimulus, the rate and depth of respiration decrease, and the CO2 content of the blood increases. Increased Carbon Dioxide Production. Carbon dioxide is a product of the body’s metabolic processes, generating a substantial amount of acid that must be excreted by the lungs or kidney to prevent acidosis. An increase in CO2 production can result from numerous processes, including exercise, fever, sepsis, and burns. For example, CO2 production increases by approximately 13% for each 1°C rise in temperature above normal.27 Nutrition also affects the production of carbon dioxide. A carbohydrate-rich diet produces larger amounts of CO2 than one containing reasonable amounts of protein and fat. Although excess carbon dioxide production can lead to an increase in PCO2, it seldom does. In cases of healthy persons, an increase in CO2 is usually matched by an increase in CO2 elimination by the lungs. In contrast, persons with respiratory diseases may be unable to eliminate the excess CO2. CHAPTER 34 RESPIRATORY ACID-BASE IMBALANCE ➤ Respiratory acid-base imbalances are due to a primary disturbance in PCO2, reflecting an increase or decrease in alveolar ventilation. ➤ Respiratory acidosis, or hypercapnia, represents an increase in PCO2 and a decrease in plasma pH, resulting from a decrease in effective alveolar ventilation. Compensatory mechanisms include increased conservation and generation of HCO3− and elimination of H+ by the kidney. ➤ Respiratory alkalosis, or hypocapnia, represents a decrease in PCO2 and an increase in plasma pH, resulting from increased alveolar ventilation. Compensatory mechanisms include increased elimination of HCO3− and conservation of H+ by the kidney. Disorders of Acid-Base Balance 17 ache, blurred vision, irritability, muscle twitching, and psychological disturbances can occur with acute respiratory acidosis. If the condition is severe and prolonged, it can cause an increase in CSF pressure and papilledema. Impaired consciousness, ranging from lethargy to coma, develops as the PCO2 rises. Paralysis of extremities may occur, and there may be respiratory depression. Less severe forms of acidosis often are accompanied by warm and flushed skin, weakness, and tachycardia. Treatment The treatment of acute and chronic respiratory acidosis is directed toward improving ventilation. In severe cases, mechanical ventilation may be necessary. The treatment of respiratory acidosis due to respiratory failure is discussed in Chapter 31. RESPIRATORY ALKALOSIS Manifestations Respiratory acidosis is associated with a plasma pH below 7.35 and an arterial PCO2 above 50 mm Hg (see Table 34-4). The signs and symptoms of respiratory acidosis depend on the rapidity of onset and whether the condition is acute or chronic. Because respiratory acidosis often is accompanied by hypoxemia, the manifestations of respiratory acidosis often are intermixed with those of oxygen deficit. Carbon dioxide readily crosses the blood–brain barrier, exerting its effects by changing the pH of brain fluids. Elevated levels of CO2 produce vasodilation of cerebral blood vessels. Head- TABLE 34-4 Respiratory alkalosis is a systemic acid-base disorder characterized by a primary decrease in plasma PCO2, also referred to as hypocapnia, which produces an elevation in pH and a subsequent decrease in HCO3−.25,27,28 Because respiratory alkalosis can occur suddenly, a compensatory decrease in bicarbonate level may not occur before respiratory correction has taken place. Causes Respiratory alkalosis is caused by hyperventilation or a respiratory rate in excess of that needed to maintain normal Causes and Manifestations of Respiratory Acidosis Causes Manifestations Depression of Respiratory Center Drug overdose Head injury Blood pH, CO2 , HCO3− pH decreased PCO2 (primary) increased HCO3− (compensatory) increased Lung Disease Bronchial asthma Emphysema Chronic bronchitis Pneumonia Pulmonary edema Respiratory distress syndrome Airway Obstruction, Disorders of Chest Wall and Respiratory Muscles Paralysis of respiratory muscles Chest injuries Kyphoscoliosis Extreme obesity Treatment with paralytic drugs Breathing Air With High CO2 Content Neural Function Dilation of cerebral vessels and depression of neural function Headache Weakness Behavior changes Confusion Depression Paranoia Hallucinations Tremors Paralysis Stupor and coma Skin Skin warm and flushed Signs of Compensation Acid urine 18 UNIT VIII Renal Function and Fluids and Electrolytes plasma PCO2 levels (Table 34-5). It may occur as the result of central stimulation of the medullary respiratory center or stimulation of peripheral (e.g., carotid chemoreceptor) pathways to the medullary respiratory center.25 Mechanical ventilation may produce respiratory alkalosis if the rate and tidal volume are set so that CO2 elimination exceeds CO2 production. Carbon dioxide crosses the alveolar capillary membrane 20 times more rapidly than oxygen. Therefore, the increased minute ventilation may be necessary to maintain adequate oxygen levels while producing a concomitant decrease in CO2 levels. In some cases, respiratory alkalosis may be induced medically as a means of controlling disorders such as severe intracranial hypertension.27 Central stimulation of the medullary respiratory center occurs with anxiety, pain, pregnancy, febrile states, sepsis, encephalitis, and salicylate toxicity. Respiratory alkalosis has long been recognized as a common acid-base disorder in critically ill patients and is a consistent finding in both septic shock and the systemic inflammatory response syndrome27 (see Chapter 28). Progesterone increases ventilation in women; during the progesterone phase of the menstrual cycle, normal women increase their PCO2 values by 2 to 4 mm Hg and their pH by 0.01 to .02.3 Women also develop substantial hypocapnia during pregnancy, most notably during the last trimester, with PCO2 values of 29 to 32 mm Hg.3,27 One of the most common causes of respiratory alkalosis is the hyperventilation syndrome, which is characterized by recurring episodes of overbreathing often associated with anxiety. Persons experiencing panic attacks frequently present in the emergency room with manifestations of acute respiratory alkalosis. Hypoxemia exerts its effect on pH through the peripheral chemoreceptors in the carotid bodies. Stimulation of peripheral chemoreceptors occurs in conditions that cause hypoxemia with relatively unimpaired CO2 trans- TABLE 34-5 port such as exposure to high altitudes, asthma, and respiratory disorders that decrease lung compliance. Manifestations Respiratory alkalosis manifests with a decrease in PCO2 and a deficit in H2CO3 (see Table 34-5). In respiratory alkalosis, the pH is above 7.45, arterial PCO2 is below 35 mm Hg, and plasma HCO3− levels usually are below 24 mEq/L (24 mmol/L). The signs and symptoms of respiratory alkalosis are associated with hyperexcitability of the nervous system and a decrease in cerebral blood flow. Alkalosis increases protein binding of extracellular calcium. This reduces ionized calcium levels, causing an increase in neuromuscular excitability. A decrease in the CO2 content of the blood causes constriction of cerebral blood vessels. Because CO2 crosses the blood–brain barrier rather quickly, the manifestations of acute respiratory alkalosis are usually of sudden onset. The person often experiences light-headedness, dizziness, tingling, and numbness of the fingers and toes. These manifestations may be accompanied by sweating, palpitations, panic, air hunger, and dyspnea. Chvostek’s and Trousseau’s signs may be positive (see Chapter 33), and tetany and convulsions may occur. Because CO2 provides the stimulus for short-term regulation of respiration, short periods of apnea may occur in persons with acute episodes of hyperventilation. Treatment The treatment of respiratory alkalosis focuses on measures to correct the underlying cause. Hypoxia may be corrected by administration of supplemental oxygen. Changing ventilator settings may be used to prevent or treat respiratory alkalosis in persons who are being mechanically ventilated. Persons with hyperventilation syndrome may benefit from reassurance, rebreathing from a paper bag during symptomatic attacks, and attention to the psychological stress. Causes and Manifestations of Respiratory Alkalosis Causes Manifestations Excessive Ventilation Anxiety and psychogenic hyperventilation Hypoxia and reflex stimulation of ventilation Lung disease that reflexly stimulates ventilation Stimulation of respiratory center Elevated blood ammonia level Salicylate toxicity Encephalitis Fever Mechanical ventilation Blood pH, CO2 , HCO3− pH increased PCO2 (primary) decreased HCO3− (compensatory) decreased Neural Function Constriction of cerebral vessels and increased neuronal excitability Dizziness, panic, light-headedness Tetany Numbness and tingling of fingers and toes Positive Chvostek’s and Trousseau’s signs Seizures Cardiovascular Function Cardiac dysrhythmias CHAPTER 34 In summary, acidosis describes a decrease in pH, and alkalosis describes an increase in pH. Acid-base disorders may be caused by alterations in the body’s volatile acids (i.e., respiratory acidosis or respiratory alkalosis) or nonvolatile or fixed acids (i.e., metabolic acidosis or metabolic alkalosis). Acidosis and alkalosis typically involve a primary or initiating event and a compensatory or adaptive state that results from homeostatic mechanisms that attempt to prevent or correct large changes in pH. A mixed acid-base disorder is one in which there is both a primary and a compensatory change in acid-base balance. Metabolic acidosis is defined as a decrease in pH due to a decrease in the HCO3− ion, and metabolic alkalosis as an increase in pH due to an increase in the HCO3− ion. It is caused by an increased production of nonvolatile metabolic acids such as lactic acids or ketoacids, decreased acid excretion by the kidney, excessive loss of HCO3− as in diarrhea, or an increase in Cl− ion. Metabolic acidosis may present with an increase in anion gap in which sodium bicarbonate is replaced by the sodium salt of the defending anion or with a normal anion gap as when HCO3− is replaced by Cl−. Metabolic alkalosis involves factors related to the generation of a loss of H+ ion or gain of HCO3− ion and those that serve to maintain it by interfering with the excretion of excess HCO3−. Factors that serve to maintain the alkalosis include decreased glomerular filtration rate, extracellular volume contraction, hypokalemia, hypochloremia, and aldosterone excess. Respiratory acidosis reflects an increase in PCO2 levels and is caused by conditions that impair alveolar ventilation. It can occur as an acute disorder in which there is a rapid rise in PCO2, a minimal increase in plasma HCO3−, and a large decrease in pH. Respiratory alkalosis is caused by conditions that cause hyperventilation and a reduction in PCO2 levels. Because respiratory alkalosis often occurs suddenly, a compensatory decrease in HCO3− levels may not occur before correction has been accomplished. The signs and symptoms of acidosis and alkalosis reflect alterations in body function associated with the disorder causing the acid-base disturbance, the effect of the change of pH on body function, and the body’s attempt to correct and maintain the pH within a normal physiologic range. In general, neuromuscular excitability is decreased in acidosis and increased in alkalosis. REVIEW EXERCISES A 34-year-old woman with diabetes is admitted to the emergency in a stuporous state. Her skin is flushed and warm, her breath has a sweet odor, her pulse is rapid and weak, and her respirations are rapid and deep. Her initial laboratory tests indicate a blood sugar of 320 mg/dL, serum bicarbonate of 12 mEq/L (normal, 24 to 27 mEq/L), and a pH of 7.1. A. What is the most likely cause of her lowered pH and bicarbonate levels? B. How would you account for her rapid and deep respirations? Disorders of Acid-Base Balance 19 C. Using the Henderson-Hasselbalch equation and the solubility coefficient for carbon dioxide that is given in this chapter, what would you expect her PCO2 to be? D. How would you explain her warm, flushed skin and stuporous mental state? A 65-year-old man with chronic obstructive lung disease has been using low-flow oxygen therapy because of difficulty in maintaining adequate oxygenation of his blood. He has recently had a severe respiratory tract infection and has had increasing difficulty breathing. He is admitted to the emergency room because he has become increasingly lethargic and his wife has had trouble arousing him. She relates that he had “turned his oxygen way up” because of difficulty breathing. A. What is the most likely cause of this man’s problem? B. How would you explain the lethargy and difficulty in arousal? C. Blood gases, drawn on admission to the emergency room, indicated a PO2 of 85 mm Hg and a PCO2 of 90 mm Hg. His serum bicarbonate levels were 34 mEq/L. What is his pH? D. What would be the main goal of his treatment in terms of acid-base balance? References 1. Rose B. D. (2001). Clinical physiology of acid-base and electrolyte disorders (5th ed., pp. 302, 325–364, 578–647, 669). New York: McGraw-Hill. 2. Guyton A., Hall J. E. (2000). Textbook of medical physiology (10th ed., pp. 346–363). Philadelphia: W. B. Saunders. 3. Adrogu′e H. E., Adrogu′e H. J. (2001). Acid-base physiology. Respiratory Care 46, 328–341. 4. Shapiro J. I., Kaehny W. D. (2003). Pathogenesis and management of metabolic acidosis and alkalosis. In Schrier R. W. (ed). Renal and electrolyte disorders (pp.115–153). Philadelphia: Lippincott Williams & Wilkins. 5. Rhoades R. A., Tanner G. A. (1996). Medical physiology (pp. 465–483). Boston: Little, Brown. 6. Metheny N. M. (2000). Fluid and electrolyte balance (4th ed., p. 162). Philadelphia: J. B. Lippincott. 7. Kraut J. A., Madias N. E. (2001). Approach to patients with acid-base disorders. Respiratory Care 46, 392–402. 8. Adrogue H. J., Madias N. E. (1998). Management of lifethreatening acid-base disorders: First of two parts. New England Journal of Medicine 338, 26–34. 9. Gauthier P. M., Szerlip H. M. (2002). Metabolic acidosis in the intensive care unit. Critical Care Medicine 18, 289–308. 10. Swenson E. R. (2001). Metabolic acidosis. Respiratory Care 46, 342–353. 11. Rothman S. M. (1999). Mutations of the mitochondrial genome: Clinical overview and possible pathophysiology of cell damage. Biochemical Society Symposia 66, 111–122. 12. Howell N. (1999). Human mitochondrial diseases: Answering questions and questioning answers. International Review of Cytology 186, 49–116. 13. Uribarri J., Oh M. S., Carroll H. J. (1998). D-Lactic acidosis: A review of clinical presentation, biochemical features and pathophysiological mechanisms. Medicine (Baltimore) 77(2), 73–82. 20 UNIT VIII Renal Function and Fluids and Electrolytes 14. Umpierrez G. E., DiGirolamo M., Tuvlin J. A., et al. (2000). Differences in metabolic and hormonal milieu in diabetic and alcohol-induced ketoacidosis. Journal of Critical Care 15(2), 52–59. 15. Meyer R. J., Beard M. E., Ardagh M. W., Henderson S. (2000). Methanol poisoning. New Zealand Medical Journal 113(1102), 3–11. 16. Scalley RD., Smart M. L., Archie T. E. (2002). Treatment of ethylene glycol poisoning. American Family Physician 66, 807–812. 17. Egbert P. A., Abraham K. (1999). Ethylene glycol intoxication: Pathophysiology, diagnosis, and emergency management. ANNA Journal 26, 295–300. 18. Brent J., McMartin K., Phillips S. (2001). Fomepizole for treatment of methanol poisoning. New England Journal of Medicine 344, 424–429. 19. Powers F. (1999). The role of chloride in acid-base balance. Journal of Intravenous Nursing 22, 286–291. 20. Alpern R. J., Sakhaee K. (1997). The clinical spectrum of chronic metabolic acidosis: Homeostatic mechanisms produce 21. 22. 23. 24. 25. 26. 27. 28. significant morbidity. American Journal of Kidney Diseases 29, 291–302. Forsythe S. M., Schmidt G. A. (2000). Sodium bicarbonate for the treatment of lactic acidosis. Chest 117, 260–267. Khanna A., Kurtzman N. A. (2001). Metabolic alkalosis. Respiratory Care 46, 354–365. Galla J. H. (2000). Metabolic alkalosis. Journal of the American Society of Nephrology 11, 369–375. Adrogue H. J., Madias N. E. (1998). Management of lifethreatening acid-base disorders. New England Journal of Medicine 338, 107–111. Kaehny W. D. (2003). Pathogenesis and management of respiratory and mixed acid-base disorders. In Schrier R. W. (ed). Renal and electrolyte disorders (pp. 154–170). Philadelphia: Lippincott Williams & Wilkins. Epstein S. K., Singh N. (2001). Respiratory acidosis. Respiratory Care 46, 366–383. Laffey J. H., Kavenaugh B. P. (2002). Hypocapnia. New England Journal of Medicine 347, 43–53. Foste G. T., Vaziri N. D., Sassoon C. S. H. (2001). Respiratory alkalosis. Respiratory Care 46, 384–391.